Dasatinib Impurity D |
|
| Synonyms: Deschlorodasatinib; 2-[[6-[4-(2-Hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-N-(2-methylphenyl)-5-thiazolecarboxamide, | |
| Cat. No.: D25004 | CAS No.: 1184919-23-0 |
| MDL.: | Formula: C22H27N7O2S |
| F.W.453.56 | Purity: 99% |
| Storage: No Data Available | |
|   | |
| Catalog Number: | D25004 | CAS No.: | 1184919-23-0 | |
| MDL: | Formula: | C22H27N7O2S | ||
| F.W.: | 453.56 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Lombardo, L.J., et al: J. Med. Chem., 47, 6658 (2004), Shah, N. P., et al.: Science, 305, 399 (2004), O’Hare, T., et al.: Curr. Opin. Genet. Dev., 16, 92 (2006), | |||
| Application: | Deschloro-dasatinib, is the impurity of Dasatinib, which is a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. It is also an Antineoplastic. | |||
| Category: | Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors | |||








